Nextgen Biomed Ltd (TLV:NXGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 68.40
+0.20 (0.29%)
At close: Jan 9, 2026
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 10.12 million as of January 9, 2026. Its market cap has increased by 53.12% in one year.
Market Cap
10.12M
Enterprise Value
11.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.40
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 10.12M, a decrease of -46.65%. That is a compound annual growth rate of -4.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 10.12M | 54.76% |
| Dec 31, 2024 | 6.54M | -28.83% |
| Dec 31, 2023 | 9.19M | -66.19% |
| Dec 29, 2022 | 27.18M | -55.05% |
| Dec 30, 2021 | 60.47M | -24.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 115.77B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |